Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors

被引:19
|
作者
Cameron, D. R. [1 ,2 ]
Lin, Y. -H. [3 ]
Trouillet-Assant, S. [4 ]
Tafani, V. [4 ]
Kostoulias, X. [1 ,2 ]
Mouhtouris, E. [5 ]
Skinner, N. [6 ]
Visvanathan, K. [6 ]
Baines, S. L. [3 ]
Howden, B. [3 ]
Monk, I. R. [3 ]
Laurent, F. [4 ]
Stinear, T. P. [3 ]
Howden, B. P. [3 ,7 ,8 ]
Peleg, A. Y. [1 ,2 ,9 ,10 ]
机构
[1] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Melbourne, Vic, Australia
[2] Monash Univ, Dept Microbiol, Melbourne, Vic, Australia
[3] Univ Melbourne, Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[4] Hosp Civils Lyon, Int Ctr Infectiol Res, French Natl Reference Ctr Staphylococci, Dept Microbiol, Lyon, France
[5] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia
[6] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[7] Austin Hlth, Infect Dis Dept, Melbourne, Vic, Australia
[8] Austin Hlth, Microbiol Dept, Melbourne, Vic, Australia
[9] Monash Univ, Alfred Hosp, Dept Infect Dis, Melbourne, Vic 3004, Australia
[10] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia
基金
英国医学研究理事会;
关键词
Accessory gene regulator agr; alpha toxin; Persistence; Staphylococcus aureus; Vancomycin-intermediate Staphylococcus; aureus; Virulence; REDUCED SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; ALPHA-HEMOLYSIN; IN-VIVO; MUTATION; AGR; INFECTION; BACTEREMIA; ACTIVATION; EVOLUTION;
D O I
10.1016/j.cmi.2017.03.027
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Vancomycin-intermediate Staphylococcus aureus (VISA) is associated with genetic changes that may also impact upon pathogenicity. In the current study, we compared the virulence of clinical VISA strains with their isogenic vancomycin-susceptible progenitors (VSSA). Methods: Production of the critical virulence protein, a toxin, was assessed using Western blot analysis and was correlated to agr activity using a bioluminescent agr-reporter. Cytotoxicity and intracellular persistence were compared ex vivo for VSSA and VISA within non-professional phagocytes (NPP). Virulence and host immune responses were further explored in vivo using a murine model of bacteraemia. Results: VISA isolates produced up to 20-fold less alpha toxin compared with VSSA, and this was corroborated by either loss of agr activity due to agr mutation, or altered agr activity in the absence of mutation. VISA were less cytotoxic towards NPP and were associated with enhanced intracellular persistence, suggesting that NPP may act as a reservoir for VISA. Infection with VSSA strains produced higher mortality in a murine bacteraemia model (>= 90% 7-day mortality) compared with infection with VISA isolates (20% to 50%, p<0.001). Mice infected with VISA produced a dampened immune response (4.6-fold reduction in interleukin-6, p<0.001) and persistent organ bacterial growth was observed for VISA strains out to 7 days. Conclusions: These findings highlight the remarkable adaptability of S. aureus, whereby, in addition to having reduced antibiotic susceptibility, VISA alter the expression of pathogenic factors to circumvent the host immune response to favour persistent infection over acute virulence. (C) 2017 The Authors. Published by Elsevier Ltd
引用
收藏
页码:767 / 773
页数:7
相关论文
共 50 条
  • [1] Heteroresistance in Vancomycin-Intermediate Staphylococcus aureus (VISA), susceptible or resistant?
    Labarca, Jaime
    REVISTA CHILENA DE INFECTOLOGIA, 2015, 32 (05): : 497 - 498
  • [2] DIFFERENTIAL INFLAMMATORY RESPONSES IN MACROPHAGES BY VANCOMYCIN-SUSCEPTIBLE STAPHYLOCOCCUS AUREUS AND VANCOMYCIN-INTERMEDIATE STAPHYLOCOCCUS AUREUS
    Lee, H. -S.
    Kuo, T. -Y.
    INFLAMMATION RESEARCH, 2011, 60 : 159 - 159
  • [3] Vancomycin-intermediate resistance in Staphylococcus aureus
    Hiramatsu, Keiichi
    Kayayama, Yuki
    Matsuo, Miki
    Aiba, Yoshifumi
    Saito, Michie
    Hishinuma, Tomomi
    Iwamoto, Akira
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (04) : 213 - 224
  • [4] Vancomycin-intermediate Staphylococcus aureus in Korea
    Kim, MN
    Pai, CH
    Woo, JH
    Ryu, JS
    Hiramatsu, K
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (10) : 3879 - 3881
  • [5] Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
    Zhang, Shanshan
    Sun, Xiaoxi
    Chang, Wenjiao
    Dai, Yuanyuan
    Ma, Xiaoling
    PLOS ONE, 2015, 10 (08):
  • [6] In Vitro Susceptibilities and Molecular Analysis of Vancomycin-Intermediate and Vancomycin-Resistant Staphylococcus aureus Isolates
    Saravolatz, Louis D.
    Pawlak, Joan
    Johnson, Leonard B.
    CLINICAL INFECTIOUS DISEASES, 2012, 55 (04) : 582 - 586
  • [7] The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
    Appelbaum, PC
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 16 - 23
  • [8] Draft Genome Sequences of Vancomycin-Susceptible Staphylococcus aureus Related to Heterogeneous Vancomycin-Intermediate S. aureus
    Ramaraj, Thiruvarangan
    Matyi, Stephanie A.
    Sundararajan, Anitha
    Lindquist, Ingrid E.
    Devitt, Nicolas P.
    Schilkey, Faye D.
    Lamichhane-Khadka, Reena
    Hoyt, Peter R.
    Mudge, Joann
    Gustafson, John E.
    GENOME ANNOUNCEMENTS, 2014, 2 (05)
  • [9] Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive Staphylococcus aureus Strains
    Jin, Ye
    Yu, Xiao
    Zhang, Shuntian
    Kong, Xiaoyang
    Chen, Weiwei
    Luo, Qixia
    Zheng, Beiwen
    Xiao, Yonghong
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [10] Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
    Hafer, Cory
    Lin, Ying
    Kornblum, John
    Lowy, Franklin D.
    Uhlemann, Anne-Catrin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5845 - 5851